201 related articles for article (PubMed ID: 26743478)
21. Differentiation between Spitz nevi and malignant melanomas by interphase fluorescence in situ hybridization.
Wettengel GV; Draeger J; Kiesewetter F; Schell H; Neubauer S; Gebhart E
Int J Oncol; 1999 Jun; 14(6):1177-83. PubMed ID: 10339676
[TBL] [Abstract][Full Text] [Related]
22. Genetic changes in neoplasms arising in congenital melanocytic nevi: differences between nodular proliferations and melanomas.
Bastian BC; Xiong J; Frieden IJ; Williams ML; Chou P; Busam K; Pinkel D; LeBoit PE
Am J Pathol; 2002 Oct; 161(4):1163-9. PubMed ID: 12368190
[TBL] [Abstract][Full Text] [Related]
23. Melanoma associated with blue nevus and melanoma mimicking cellular blue nevus: a clinicopathologic study of 10 cases on the spectrum of so-called 'malignant blue nevus'.
Granter SR; McKee PH; Calonje E; Mihm MC; Busam K
Am J Surg Pathol; 2001 Mar; 25(3):316-23. PubMed ID: 11224601
[TBL] [Abstract][Full Text] [Related]
24. Loss of p16 expression and copy number changes of CDKN2A in a spectrum of spitzoid melanocytic lesions.
Harms PW; Hocker TL; Zhao L; Chan MP; Andea AA; Wang M; Harms KL; Wang ML; Carskadon S; Palanisamy N; Fullen DR
Hum Pathol; 2016 Dec; 58():152-160. PubMed ID: 27569296
[TBL] [Abstract][Full Text] [Related]
25. Melanocytic Skin Neoplasms: What Lesson From Genomic Aberrations?
Urso C
Am J Dermatopathol; 2019 Sep; 41(9):623-629. PubMed ID: 31433323
[TBL] [Abstract][Full Text] [Related]
26. A comparative study of proliferative nodules and lethal melanomas in congenital nevi from children.
Yélamos O; Arva NC; Obregon R; Yazdan P; Wagner A; Guitart J; Gerami P
Am J Surg Pathol; 2015 Mar; 39(3):405-15. PubMed ID: 25517953
[TBL] [Abstract][Full Text] [Related]
27. Comprehensive Clinical, Histopathologic, and Molecular Analysis and Long-term Follow-up of Patients With Nodal Blue Nevi.
Colebatch AJ; Adhikari C; Diefenbach RJ; Rawson RV; Ferguson PM; Rizos H; Long GV; McCarthy SW; Thompson JF; Wilmott JS; Scolyer RA
Am J Surg Pathol; 2022 Aug; 46(8):1048-1059. PubMed ID: 35439782
[TBL] [Abstract][Full Text] [Related]
28. Correlating array comparative genomic hybridization findings with histology and outcome in spitzoid melanocytic neoplasms.
Ali L; Helm T; Cheney R; Conroy J; Sait S; Guitart J; Gerami P
Int J Clin Exp Pathol; 2010 Jun; 3(6):593-9. PubMed ID: 20661407
[TBL] [Abstract][Full Text] [Related]
29. Copy number variations and clinical outcome in atypical spitz tumors.
Raskin L; Ludgate M; Iyer RK; Ackley TE; Bradford CR; Johnson TM; Fullen DR
Am J Surg Pathol; 2011 Feb; 35(2):243-52. PubMed ID: 21263245
[TBL] [Abstract][Full Text] [Related]
30. Somatic mutations in GNAQ in amelanotic/hypomelanotic blue nevi.
Emley A; Nguyen LP; Yang S; Mahalingam M
Hum Pathol; 2011 Jan; 42(1):136-40. PubMed ID: 21056896
[TBL] [Abstract][Full Text] [Related]
31. Molecular cytogenetic analysis of Spitz nevi shows clear differences to melanoma.
Bastian BC; Wesselmann U; Pinkel D; Leboit PE
J Invest Dermatol; 1999 Dec; 113(6):1065-9. PubMed ID: 10594753
[TBL] [Abstract][Full Text] [Related]
32. Integrated Genomic Classification of Melanocytic Tumors of the Central Nervous System Using Mutation Analysis, Copy Number Alterations, and DNA Methylation Profiling.
Griewank KG; Koelsche C; van de Nes JAP; Schrimpf D; Gessi M; Möller I; Sucker A; Scolyer RA; Buckland ME; Murali R; Pietsch T; von Deimling A; Schadendorf D
Clin Cancer Res; 2018 Sep; 24(18):4494-4504. PubMed ID: 29891723
[No Abstract] [Full Text] [Related]
33. Genetic Background of Iris Melanomas and Iris Melanocytic Tumors of Uncertain Malignant Potential.
van Poppelen NM; Vaarwater J; Mudhar HS; Sisley K; Rennie IG; Rundle P; Brands T; van den Bosch QCC; Mensink HW; de Klein A; Kiliç E; Verdijk RM
Ophthalmology; 2018 Jun; 125(6):904-912. PubMed ID: 29371009
[TBL] [Abstract][Full Text] [Related]
34. CYSLTR2-mutant Cutaneous Melanocytic Neoplasms Frequently Simulate "Pigmented Epithelioid Melanocytoma," Expanding the Morphologic Spectrum of Blue Tumors: A Clinicopathologic Study of 7 Cases.
Goto K; Pissaloux D; Paindavoine S; Tirode F; de la Fouchardière A
Am J Surg Pathol; 2019 Oct; 43(10):1368-1376. PubMed ID: 31162285
[TBL] [Abstract][Full Text] [Related]
35. Fluorescence in situ hybridization for distinguishing cellular blue nevi from blue nevus-like melanoma.
Gammon B; Beilfuss B; Guitart J; Busam KJ; Gerami P
J Cutan Pathol; 2011 Apr; 38(4):335-41. PubMed ID: 21251038
[TBL] [Abstract][Full Text] [Related]
36. BRAF and NRAS mutations in spitzoid melanocytic lesions.
Fullen DR; Poynter JN; Lowe L; Su LD; Elder JT; Nair RP; Johnson TM; Gruber SB
Mod Pathol; 2006 Oct; 19(10):1324-32. PubMed ID: 16799476
[TBL] [Abstract][Full Text] [Related]
37. Growth factor and cytogenetic abnormalities in cultured nevi and malignant melanomas.
Richmond A; Fine R; Murray D; Lawson DH; Priest JH
J Invest Dermatol; 1986 Mar; 86(3):295-302. PubMed ID: 3745955
[TBL] [Abstract][Full Text] [Related]
38. Persistent and recurrent blue nevi.
Harvell JD; White WL
Am J Dermatopathol; 1999 Dec; 21(6):506-17. PubMed ID: 10608242
[TBL] [Abstract][Full Text] [Related]
39. Melanoma arising in association with blue nevus: a clinical and pathologic study of 24 cases and comprehensive review of the literature.
Loghavi S; Curry JL; Torres-Cabala CA; Ivan D; Patel KP; Mehrotra M; Bassett R; Prieto VG; Tetzlaff MT
Mod Pathol; 2014 Nov; 27(11):1468-78. PubMed ID: 24743221
[TBL] [Abstract][Full Text] [Related]
40. Targeted next generation sequencing reveals unique mutation profile of primary melanocytic tumors of the central nervous system.
van de Nes J; Gessi M; Sucker A; Möller I; Stiller M; Horn S; Scholz SL; Pischler C; Stadtler N; Schilling B; Zimmer L; Hillen U; Scolyer RA; Buckland ME; Lauriola L; Pietsch T; Waha A; Schadendorf D; Murali R; Griewank KG
J Neurooncol; 2016 May; 127(3):435-44. PubMed ID: 26744134
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]